Breast cancer, side population cells and ABCG2 expression

Cancer Letters

Volumn 323, Issue 1, 2012, Pages 97-105

  Britton, K M ^a   Eyre, R ^b   Harvey, I J ^a   Stemke Hale, K ^c   Browell, D ^d   Lennard, T W J ^b   Meeson, A P ^a,e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF TEXAS   (United States)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e INSTITUTE OF HUMAN GENETICS   (United Kingdom)

Author keywords

ABCG2; Breast cancer; Cancer stem cells; Drug resistance; Side population

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; MESSENGER RNA; MITOXANTRONE; TUMOR MARKER;

ABCG2 GENE; ARTICLE; ASPIRATION BIOPSY; CANCER CELL CULTURE; CANCER RESISTANCE; CELL ISOLATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DISEASE ASSOCIATION; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIDE POPULATION CELL; TRIPLE NEGATIVE BREAST CANCER; TUMOR GENE;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIDE-POPULATION CELLS;

EID: 84861815719     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.03.041     Document Type: Article

References (39)

1. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A. A distinct " side population" of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Science 2004, 1010:14228-14233.
2. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. PNAS 2004, 101:781-786.
3. - cancer cells are similarly tumorigenic. Cancer Research 2005, 65:6207-6219.
4. Goodell M., Brose K., Paradis G., Conner A., Mulligan R. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Journal of Experimental Medicine 1996, 183:1797-1806.
5. Zhou S., Morris J.J., Barnes Y., Lan L., Schuetz J.D., Sorrentino B.P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proceedings of the National Academy of Sciences 2002, 99:12339-12344.
6. Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumourigenesis. Breast Cancer Research 2002, 4:197-201.
7. Dick J.E. Breast cancer stem cells revealed. Proceedings of the National Academy of Sciences 2003, 100:3547-3549.
8. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
9. Ailles L.E., Weissman I.L. Cancer stem cells in solid tumors. Current Opinion in Biotechnology 2007, 18:460-466.
10. Alvi A., Clayton H., Joshi C., Enver T., Ashworth A., Vivanco M.d., Dale T., Smalley M. Functional and molecular characterisation of mammary side population cells. Breast Cancer Research 2003, 5:R1-R8.
11. pos cells in the mouse mammary gland represent an enriched progenitor cell population. Developmental Biology 2002, 245:42-56.
12. Clayton H., Titley I., Vivanco M. Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Experimental Cell Research 2004, 297:444-460.
13. Clarke R., Spence K., Anderson E., Howell A., Okano H., Potten C. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Developmental Biology 2005, 277:443-456.
14. Jonker J.W., Freeman J., Bolscher E., Musters S., Alvi A.J., Titley I., Schinkel A.H., Dale T.C. Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells 2005, 23:1059-1065.
15. Behbod F., Xian W., Shaw C., Hilsenbeck S., Tsimelzon A., Rosen J. Transcriptional profiling of mammary gland side population cells. Stem Cells 2006, 24:1065-1074.
16. Nakanishi T., Chumsri S., Khakpour N., Brodie A.H., Leyland-Jones B., Hamburger A.W., Ross D.D., Burger A.M. Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling. British Journal of Cancer 2010, 102:815-826.
17. Szotek P.P., Pieretti-Vanmarcke R., Masiakos P.T., Dinulescu D.M., Connolly D., Foster R., Dombkowski D., Preffer F., MacLaughlin D.T., Donahoe P.K. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proceedings of the National Academy of Sciences 2006, 103:11154-11159.
18. Wu C., Wei Q., Utomo V., Nadesan P., Whetstone H., Kandel R., Wunder J.S., Alman B.A. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Research 2007, 67:8216-8222.
19. Shi G., Xu Y., Fan J., Zhou J., Yang X., Qiu S., Liao Y., Wu W., Ji Y., Ke A., Ding Z., He Y., Wu B., Yang G., Qin W., Zhang W., Zhu J., Min Z., Wu Z. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. Journal of Cancer Research and Clinical Oncology 2008, 134:1155-1163.
20. Ho M., Ng A., Lam S., Hung J. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Research 2007, 67:4827-4833.
21. Yusa K., Tsuruo T. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Research 1989, 49.
22. Detre S., Saclani Jotti G., Dowsett M. A " quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. Journal of Clinical Pathology 1995, 48:876-878.
23. Steiniger S., Coppinger J., Krüger J., Yates J.r., Janda K. Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population. Stem Cells 2008, 26:3037-3046.
24. Diestra J., Scheffer G., Català I., Maliepaard M., Schellens J., Scheper R., Germà-Lluch J., Izquierdo M. Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. Journal of Pathology 2002, 198:213-219.
25. Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C.L.M., Schinkel A.H., van de Vijver M.J., Scheper R.J., Schellens J.H.M. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Research 2001, 61:3458-3464.
26. Faneyte I.F., Kristel P.M.P., Maliepaard M., Scheffer G.L., Scheper R.J., Schellens J.H.M., van de Vijver M.J. Expression of the breast cancer resistance protein in breast cancer. Clinical Cancer Research 2002, 8:1068-1074.
27. Menard S., Valagussa P., Pilotti S., Gianni L., Biganzoli E., Boracchi P., Tomasic G., Casalini P., Marubini E., Colnaghi M., Cascinelli N., Bonadonna G. Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. Journal of Clinical Oncology 2001, 19:329-335.
28. Xie Y., Xu K., Linn D., Yang X., Guo Z., Shimelis H., Nakanishi T., Ross D., Chen H., Fazli L., Gleave M., Qiu Y. The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. Journal of Biological Chemistry 2008, 283:3349-3356.
29. Christgen M., Ballmaier M., Bruchhardt H., von Wasielewski R., Kreipe H., Lehmann U. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Molecular and Cellular Biochemistry 2007, 306:201-212.
30. Liu Y., Lu W.-L., Guo J., Du J., Li T., Wu J.-W., Wang G.-L., Wang J.-C., Zhang X., Zhang Q. A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. Journal of Controlled Release 2008, 129:18-25.
31. Yin L., Castagnino P., Assoian R.K. ABCG2 expression and side population abundance regulated by a transforming growth factor {beta}-directed epithelial-mesenchymal transition. Cancer Research 2008, 68:800-807.
32. Golebiewska A., Brons N.H.C., Bjerkvig R., Niclou S.P. Critical appraisal of the side population assay in Stem cell and cancer stem cell research. Cell Stem Cell 2011, 8:136-147.
33. Engelmann K., Shen H., Finn O.J. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Research 2008, 68:2419-2426.
34. Zhou J., Wulfkuhle J., Zhang H., Gu P., Yang Y., Deng J., Margolick J.B., Liotta L.A., Petricoin E., Zhang Y. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proceedings of the National Academy of Sciences 2007, 104:16158-16163.
35. Vibet S., Maheo K., Gore J., Dubois P., Bougnoux P., Chourpa I. Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines. Drug Metabolism and Disposition: The Biological Fate of Chemicals 2007, 35:822-828.
36. Loebinger M., Giangreco A., Groot K., Prichard L., Allen K., Simpson C., Bazley L., Navani N., Tibrewal S., Davies D., Janes S. Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. British Journal of Cancer 2008, 98:380-387.
37. Wang J., Guo L., Chen L., Zeng Y., Lu S. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Research 2007, 67:3716-3724.
38. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nature Reviews Drug Discovery 2006, 5:219-234.
39. Tadjali M., Zhou S., Rehg J., Sorrentino B.P. Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele. Stem Cells 2006, 24:1556-1563.